SEC Form D · filed February 9, 2024
RetinalGenix Technologies Inc
Offering
$4.7M
Sold
$4.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PETALUMA, CA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (8)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗